Lung Special Issue

Following a lung cancer diagnosis, staging determines the best options for treatment. Many factors are evaluated, including the size of the tumor and the extent of spread.

While there has been remarkable progress in the treatment of lung cancer in recent years, there is still a much more work to be done.

Potentially curative therapy for each stage of early lung cancer is evolving.

For some with advanced non-small cell lung cancer, the rapidly growing field of targeted therapies is boosting survival expectations.

As immunotherapy revolutionizes lung cancer treatment, scientists are considering how to make it work for more of those affected by the disease.

When determining treatment plans, some doctors are turning to genetic mutations that caused the cancer instead of the cancer type.